Haojuan Wei

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cardurion Pharmaceuticals, LLC, Janssen Pharmaceutica Nv. Active years: 2024-2025.

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

2 out of 11

Cardurion Pharmaceuticals, LLC

patents

1 out of 2,099

Janssen Pharmaceutica Nv

patents

Years Active: 2024-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466832 - Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (2025-11-11),

2. 12269813 - Crystalline form of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrazole-4-carboxamide monohydrate (2025-04-08),

3. 12006319 - Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one (2024-06-11),

This text is generated by artificial intelligence and may not be accurate.